Non-Cochrane · intervention · PM42046838

Adjunctive Use of Locally Delivered Statins in Periodontal Therapy and Pre-Implant Bone Regeneration: A Systematic Review and Meta-Analysis.

Yoshida Koki, Heller Sofia, Mousa Nur, et al. · Clinical and experimental dental research · 2026 · PubMed · doi:10.1002/cre2.70364

Findings

8 findings

Population
Adults with periodontitis (pockets 5 mm or deeper, intrabony or furcation defects) undergoing Step 2 non-surgical periodontal therapySRP plus locally delivered 1.2% atorvastatin gelSRP alone (placebo gel or no gel)Clinical attachment level (CAL), change from baseline (mm)
6 months · Periodontal clinics (Step 2 NSPT)
MD 1.70 [1.22, 2.19]
GRADE not reported
6 studies · 332 participants
Adults with periodontitis (pockets 5 mm or deeper, intrabony or furcation defects) undergoing Step 2 non-surgical periodontal therapySRP plus locally delivered 1.2% atorvastatin gelSRP alone (placebo gel or no gel)Probing pocket depth (PPD), change from baseline (mm)
6 months · Periodontal clinics (Step 2 NSPT)
MD 1.39 [0.99, 1.79]
GRADE not reported
6 studies · 332 participants
Adults with periodontitis (pockets 5 mm or deeper, intrabony or furcation defects) undergoing Step 2 non-surgical periodontal therapySRP plus locally delivered 1.2% rosuvastatin gelSRP alone (placebo gel or no gel)Probing pocket depth (PPD), change from baseline (mm)
6 months · Periodontal clinics (Step 2 NSPT)
MD 1.91 [1.35, 2.48]
GRADE not reported
4 studies · 211 participants
Adults with periodontitis (pockets 5 mm or deeper, intrabony or furcation defects) undergoing Step 2 non-surgical periodontal therapySRP plus locally delivered 1.2% rosuvastatin gelSRP alone (placebo gel or no gel)Clinical attachment level (CAL), change from baseline (mm)
6 months · Periodontal clinics (Step 2 NSPT)
MD 1.94 [1.33, 2.56]
GRADE not reported
4 studies · 211 participants
Adults with periodontitis (pockets 5 mm or deeper, intrabony or furcation defects) undergoing Step 2 non-surgical periodontal therapySRP plus locally delivered 1.2% simvastatin gelSRP alone (placebo gel or no gel)Clinical attachment level (CAL), change from baseline (mm)
6 months · Periodontal clinics (Step 2 NSPT)
MD 2.17 [1.68, 2.66]
GRADE not reported
4 studies · 228 participants
Adults with periodontitis (pockets 5 mm or deeper, intrabony or furcation defects) undergoing Step 2 non-surgical periodontal therapySRP plus locally delivered 1.2% simvastatin gelSRP alone (placebo gel or no gel)Probing pocket depth (PPD), change from baseline (mm)
6 months · Periodontal clinics (Step 2 NSPT)
MD 2.34 [1.65, 3.03]
GRADE not reported
4 studies · 228 participants
Adults with periodontitis and intrabony or Class II furcation defects undergoing Step 3 periodontal surgeryOpen flap debridement with PRF (and HA in furcation) plus locally delivered statin gel (atorvastatin or rosuvastatin)Same surgical procedure without statinClinical attachment level (CAL), change from baseline (mm)
9 months · Periodontal surgery (Step 3)
MD 0.69 [0.42, 0.96]
GRADE not reported
3 studies · 190 participants
Adults with periodontitis and intrabony or Class II furcation defects undergoing Step 3 periodontal surgeryOpen flap debridement with PRF (and HA in furcation) plus locally delivered statin gel (atorvastatin or rosuvastatin)Same surgical procedure without statinProbing pocket depth (PPD), change from baseline (mm)
9 months · Periodontal surgery (Step 3)
MD 0.80 [0.56, 1.05]
GRADE not reported
3 studies · 190 participants

Included primary studies 21

Open in Studies
StudyYearAlso included byOutcomes it informs hereTrial data
Martande 2016
Platelet-Rich Fibrin Combined With 1.2% Atorvastatin for Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled…
PMID:27294433
20163 other reviewsProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Pradeep 2016b
Platelet-Rich Fibrin With 1.2% Rosuvastatin for Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical…
PMID:27452270
20162 other reviewsProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Garg 2017
1.2% Rosuvastatin and 1.2% Atorvastatin Gel Local Drug Delivery and Redelivery in the Treatment of Class II Furcation Defects: A…
PMID:27715376
20171 other reviewProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Issa 2020
Guided tissue regeneration of intrabony defects with perforated barrier membranes, simvastatin, and EDTA root surface modification: A…
PMID:31448832
20201 other reviewnot statednot extracted yet
Pankaj 2018
Comparative evaluation of subgingivally delivered 1.2% rosuvastatin and 1% metformin gel in treatment of intrabony defects in chronic…
PMID:29802627
20181 other reviewProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Pradeep 2016a
1.2% Rosuvastatin Versus 1.2% Atorvastatin Gel Local Drug Delivery and Redelivery in Treatment of Intrabony Defects in Chronic…
PMID:26878748
20161 other reviewProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Pradeep 2017
Comparative evaluation of subgingivally delivered 1% alendronate versus 1.2% atorvastatin gel in treatment of chronic periodontitis: a…
PMID:27091596
20171 other reviewProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Christiansen 2023
Local simvastatin and inflammation during periodontal mini-flap wound healing: Exploratory results.
PMID:36017934
2023this review onlynot statednot extracted yet
Cruz 2021
Clinical efficacy of simvastatin gel combined with polypropylene membrane on the healing of extraction sockets: A triple-blind, randomized…
PMID:33715258
2021this review onlynot statednot extracted yet
Gunjiganur Vemanaradhya 2017
Effect of 1.2% of simvastatin gel as a local drug delivery system on Gingival Crevicular Fluid interleukin-6 & interleukin-8 levels in non…
PMID:28601733
2017this review onlynot statednot extracted yet
Killeen 2022
Effect of locally applied simvastatin on clinical attachment level and alveolar bone in periodontal maintenance patients: A randomized…
PMID:35622060
2022this review onlynot statednot extracted yet
Kumari 2016
Efficacy of Subgingivally Delivered 1.2% Atorvastatin in the Treatment of Chronic Periodontitis in Patients With Type 2 Diabetes Mellitus:…
PMID:27442085
2016this review onlyProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Kumari 2017
Subgingivally delivered 1.2% atorvastatin in the treatment of chronic periodontitis among smokers: a randomized, controlled clinical trial.
PMID:26988864
2017this review onlyProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Pradeep 2010
Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial.
PMID:20151799
2010this review onlyProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Pradeep 2012
Clinical efficacy of subgingivally delivered 1.2-mg simvastatin in the treatment of individuals with Class II furcation defects: a…
PMID:22348696
2012this review onlyProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Pradeep 2013 (atorvastatin)
Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: a randomized controlled clinical trial.
PMID:23030241
2013this review onlyProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Pradeep 2013 (simvastatin)
Efficacy of subgingivally delivered simvastatin in the treatment of patients with type 2 diabetes and chronic periodontitis: a randomized…
PMID:22420871
2013this review onlyProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Pradeep 2015
Efficacy of locally delivered 1.2% rosuvastatin gel to non-surgical treatment of patients with chronic periodontitis: a randomized,…
PMID:25786565
2015this review onlyProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Pradeep 2016 (furcation)
Rosuvastatin 1.2 mg In Situ Gel Combined With 1:1 Mixture of Autologous Platelet-Rich Fibrin and Porous Hydroxyapatite Bone Graft in…
PMID:26439386
2016this review onlyProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Rao 2013
Simvastatin local drug delivery in smokers with chronic periodontitis: a randomized controlled clinical trial.
PMID:23713634
2013this review onlyProbing pocket depth (PPD), change from baseline (mm); Clinical attachment level (CAL), change from baseline (mm)not extracted yet
Yaghobee 2020
Effect of Simvastatin on Bone Regeneration: A Histologic and Histomorphometric Analysis.
PMID:32084353
2020this review onlynot statednot extracted yet

Overlap with other reviews

Reviews that include the same primary studies are not independent evidence. Shared counts match studies by PMID, DOI or NCT, and otherwise by author and year (a probable match). Only the non-Cochrane dental reviews have study lists, so overlap with Cochrane reviews is not counted yet.

Review question

ElementPlanned (methods)Found (results)
PopulationAdults undergoing Step 2 subgingival instrumentation/NSPT, Step 3 periodontal surgery, Step 4 supportive periodontal care, or pre-implant bone regeneration proceduresAdults with periodontitis: 13 Step 2 trials (n=38-104), 6 Step 3 trials (n=40-110; 2 maintenance Step 4), 2 pre-implant trials (n=24-33)
InterventionLocal application of statins as an adjunctLocal atorvastatin, rosuvastatin or simvastatin gel (mostly 1.2% methylcellulose); simvastatin in pre-implant trials
ComparisonIdentical procedures with or without adjunctive statinsSRP + placebo gel; surgery with or without PRF/HA; bovine bone mineral without statin
OutcomesPPD, CAL, BoP, gingival index, plaque index; radiographic bone outcomesPPD and CAL pooled (6 months: ATV n=6, RSV n=4, SIM n=4 studies; 9 months surgical n=3); BoP, GI, PI, radiographic and ridge outcomes narrative
Study designsRCTs21 RCTs (15 in meta-analysis)
Timing6 months for Step 2 and 9 months for Step 3 meta-analysis; other follow-ups narrative6-month (Step 2) and 9-month (Step 3) pooling; follow-up 1.5 to 12 months overall

AMSTAR 2 items

Two independent extractors rated each item. Their ratings are shown side by side because they have not been reconciled yet. The overall rating follows Shea et al. 2017: one critical flaw gives Low, more than one gives Critically Low.

ItemExtractor AExtractor BAgree
1Research question includes PICO componentsYesYesyes
2Protocol established before the reviewcriticalPartial YesPartial Yesyes
3Choice of study designs explainedNoNoyes
4Comprehensive literature searchcriticalPartial YesPartial Yesyes
5Study selection in duplicateYesYesyes
6Data extraction in duplicateYesYesyes
7List of excluded studies with reasonscriticalYesYesyes
8Included studies described in detailPartial YesPartial Yesyes
9Risk of bias assessed satisfactorilycriticalRCT: Yes · NRSI: N/ANRSI: N/A · RCT: Yesno
10Funding of included studies reportedNoNoyes
11Appropriate meta-analysis methodscriticalRCT: Yes · NRSI: N/ANRSI: N/A · RCT: Partial Yesno
12Impact of risk of bias on the pooled resultsNoNoyes
13Risk of bias accounted for in interpretationcriticalYesYesyes
14Heterogeneity explainedYesYesyes
15Publication bias investigatedcriticalNoNoyes
16Conflicts of interest reportedYesYesyes
OverallLowLowyes